Company: GRCE
Filing Date: 2025-03-10
Form Type: S-3
Source: 0001140361-25-007769
Chunk: 15

Company: Grace Therapeutics, Inc.
Filing Date: 2025-03-10
Form: S-3
Chunk 15
---
382 |     |                         0 |     | *                 |
| ADAR1 Partners, LP(9)                                     |     |          1,485,307 |     |          1,552,626 |     |                   784,411 |     | 4.99%             |
| Spearhead Insurance Solutions IDF, LLC – Series ADAR1(10) |     |            515,323 |     |            509,290 |     |                     6,033 |     | *                 |
| Stonepine Capital, LP(11)                                 |     |            589,100 |     |            589,100 |     |                         0 |     | —                 |
| Joseph F. Lawler(12)                                      |     |            511,096 |     |             88,364 |     |                   422,732 |     | 3.07%             |
| SS Pharma LLC(13)                                         |     |          1,402,782 |     |            294,550 |     |                 1,419,128 |     | 9.99%             |
| Shore Pharma LLC(14)                                      |     |          1,905,358 |     |            294,550 |     |                 1,610,808 |     | 11.62%            |

| * | Represents beneficial ownership of less than one percent. |

| (1) | This Selling Stockholder holds certain warrants exercisable into shares of Common Stock. Under the terms of such warrants, the                                                                                                          
 holder may not exercise the warrants to the extent such exercise would cause such holder, together with its affiliates, to beneficially own a number of shares of Common Stock which would exceed 4.99% of the Common Stock outstanding 
 following such exercise (the “4.99% Ownership Cap”). Upon 61 days’ advance written notice to us, the holder of such warrants may from time to time increase or decrease the 4.99%                                                       |

6

TABLE OF CONTENTS

Ownership Cap percentage up to 19.99%. The number of shares of Common Stock beneficially owned prior to this offering does not include 606,186 shares underlying such warrants as a result of the 4.99% Ownership Cap and the 61 days’ advance notice provision. Mr. Orin Hirschman is the managing member of AIGH Capital Management, LLC, a Maryland limited liability company (“AIGH CM”), who is